We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Groundbreaking Ultrasound-Based Software Aids Physicians Performing Liver Tumor Ablations

By HospiMedica International staff writers
Posted on 10 Jan 2024
Print article
Image: 3D simulation of percutaneous liver tumor ablation (Photo courtesy of Techsomed)
Image: 3D simulation of percutaneous liver tumor ablation (Photo courtesy of Techsomed)

Ablation therapy, a minimally invasive treatment that employs extreme temperatures, presently lacks the tools to predict the impact of ablation based on ultrasound. Imaging plays a vital role in tumor ablation. Although ultrasound serves as a cost-efficient and patient-friendly option for real-time visualization, there exists potential for improving visualization and continuously monitoring the response of the ablation tissue. Now, a groundbreaking software can aid physicians conducting liver tumor ablations by offering visualization of the ablated area based on standard real-time ultrasound imaging.

BioTraceIO from Techsomed Medical Technologies (Rehovot, Israel) is an ultrasound-based software for tissue response prediction in liver tumor ablation that employs a unique computational algorithm to analyze ultrasound images captured during liver ablation treatment. It offers real-time visualization and tracking of the Reference Ablation Zone (RAZ), utilizing technical data from the ablation device manufacturers. After the ablation procedure, it generates a visual representation of the estimated ablation zone. This visualization is expected to match the results seen in a 24-hour contrast-enhanced CT (CECT) scan. This feature is particularly valuable, given that studies indicate a notable increase in the volume of the ablation zone 24 hours post-procedure, which is when it typically stabilizes.

The efficacy of BioTraceIO has been thoroughly tested and confirmed through a pivotal multi-center study in the USA, involving 50 patients. The study's findings show that BioTraceIO's predictions are more accurate than immediate post-procedure CECT scans in estimating the ablation zone as observed in 24-hour CECT. This is significant because the software can accurately forecast the size and shape of the ablation zone based on ultrasound images alone that correlate with CT information. The FDA has granted De Novo clearance for BioTraceIO which complements Techsomed's VisAble.IO, an AI-powered ablation treatment planning and confirmation product. The integrated solution provides a comprehensive image-guided ablation visualization framework for eliminating guesswork typically associated with thermal ablation therapy.

"Techsomed has taken a major step towards making our vision for image-guided ablation therapy a reality," said Yossi Abu, Techsomed's CEO and founder. "The FDA's De Novo clearance is game-changing as we gear up to commercialize both BioTrace.IO and VisAble.IO across multiple market segments in the USA. We are genuinely excited to be able to offer physicians smart solutions that bring a new level of precision to ablation therapy.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
EEG System
GRAEL LT

Print article
Detecto

Channels

Critical Care

view channel
Image: Detecting heart diseases using AI and the ECG (Photo courtesy of 123RF)

AI Technology Boosts ECG Capabilities for Early Heart Disease Diagnosis

Cardiovascular diseases often remain undetected until a critical event like a heart attack or stroke occurs. Early identification is key to improving outcomes, but the absence of clear symptoms complicates... Read more

Surgical Techniques

view channel
Image: ROSA Shoulder is a groundbreaking robotic system for anatomic and reverse shoulder arthroplasty (Photo courtesy of Zimmer Biomet)

World's First Robotic Assistant for Shoulder Replacement Surgery Helps Perform Highly Complex Procedures

A key challenge in performing a shoulder replacement is accurate glenoid and humeral placement, which is a critical factor for post-operative function and long-term implant survival. Now, a groundbreaking... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.